UPC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:UPC

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/10	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:UPC	Universe Pharmaceuticals Inc
2024/05/15	05 : 06	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2024/02/07	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2024/01/31	06 : 30	PR Newswire (US)	Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results	NASDAQ:UPC	Universe Pharmaceuticals Inc
2024/01/31	02 : 05	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/09/01	05 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/08/17	05 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/08/04	21 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/08/04	21 : 30	GlobeNewswire Inc.	Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/07/28	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/07/27	23 : 15	GlobeNewswire Inc.	Universe Pharmaceuticals INC Announces Share Consolidation	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/07/06	05 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/05/25	05 : 30	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/05/06	05 : 16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/03/07	22 : 00	GlobeNewswire Inc.	Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/02/15	04 : 15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2023/02/11	06 : 58	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/12/21	22 : 00	GlobeNewswire Inc.	Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/11/14	22 : 03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/11/14	22 : 00	GlobeNewswire Inc.	Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/10/28	05 : 11	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/09/28	21 : 00	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/08/17	05 : 16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/08/16	21 : 00	PR Newswire (US)	Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/07/20	05 : 07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/07/19	19 : 00	GlobeNewswire Inc.	Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/03/30	21 : 00	GlobeNewswire Inc.	Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/03/22	21 : 00	GlobeNewswire Inc.	Universe Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research Center	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/02/11	22 : 01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:UPC	Universe Pharmaceuticals Inc
2022/01/31	22 : 02	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:UPC	Universe Pharmaceuticals Inc